close 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

Strona główna・Stock List・Inovio Pharmaceuticals Inc
Search

Inovio Pharmaceuticals Inc

Closed

SectorHealthcare

1.57 -4.85

Buy

Price update 20 mar 2026, 19:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

1.5699999999999998

Max

1.6099999999999999

Key metrics

By Trading Economics

Income

49M

3.8M

Profit margin

-30,140.489

Employees

134

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+184.81% upside

Dividends

By Dow Jones

Next Earnings

12 maj 2026

Market Stats

By TradingEconomics

Market Cap

97M

Previous open

6.42

Previous close

1.57

News Sentiment

By Acuity

73%

27%

318 / 350 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

1.76 / 1.94 Support & Resistance

Inovio Pharmaceuticals Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

29 gru 2025, 15:54 UTC

Major Market Movers

Inovio Shares Drop After FDA Says No Plans to Discuss INO-3107 Application

DJ

Read

Peer Comparison

Price change

Inovio Pharmaceuticals Inc Forecast

Price Target

By TipRanks

184.81% upside

12 Months Forecast

Average 4.5 USD  184.81%

High 6 USD

Low 3 USD

Based on 2 Wall Street analysts offering 12 month price targets forInovio Pharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

1

Buy

1

Hold

0

Sell

Based on 2 analysts giving stock ratings to Inovio Pharmaceuticals Inc - Dist in the past 3 months.

Technical Score

By Trading Central

1.76 / 1.94Support & Resistance

Short Term

Bullish Evidence

Recent bullish events outweigh bearish events.

Intermediate Term

Strong Bullish Evidence

Recent bullish events outweigh bearish events.

Long Term

No Evidence

There are no events.

Sentiment

By Acuity

318 / 350 Ranking in Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Pre-tax profit

Sales

Interest expense on debt

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

903

↓-1.58%

JNJ

Johnson and Johnson

235.46

↓-0.93%

ABBV

AbbVie Inc

204.23

↓-0.92%

NVS

Novartis AG

145.89

↓-1.52%

AZN

AstraZeneca PLC

183.37

↓-2.88%
help-icon Live chat